Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Diabetes

  Free Subscription


15.06.2020

2 Am J Clin Nutr
1 Am J Hypertens
1 Angiology
1 Ann Intern Med
2 Biochem Biophys Res Commun
1 BMC Ophthalmol
1 Br J Ophthalmol
1 Circ Heart Fail
3 Circulation
9 Diabet Med
1 Diabetes
13 Diabetes Care
1 Diabetes Educ
1 Diabetes Obes Metab
3 Diabetologia
3 Eur J Endocrinol
3 J Clin Endocrinol Metab
7 J Diabetes Complications
1 J Hypertens
1 Kidney Int
1 Med J Aust
1 N Engl J Med
1 Nature
1 Ophthalmol Retina
4 Pediatr Diabetes
1 PLoS Med
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Nutr

  1. MITRI J, Tomah S, Mottalib A, Salsberg V, et al
    Effect of dairy consumption and its fat content on glycemic control and cardiovascular disease risk factors in patients with type 2 diabetes: a randomized controlled study.
    Am J Clin Nutr. 2020 Jun 10. pii: 5855517. doi: 10.1093.
    PubMed         Abstract available

  2. ROSENBERG L, Robles YP, Li S, Ruiz-Narvaez EA, et al
    A prospective study of yogurt and other dairy consumption in relation to incidence of type 2 diabetes among black women in the USA.
    Am J Clin Nutr. 2020 Jun 10. pii: 5855516. doi: 10.1093.
    PubMed         Abstract available


    Am J Hypertens

  3. SUZUKI D, Hoshide S, Kario K
    Associations between day-by-day home blood pressure variability and renal function and albuminuria in patients with and without diabetes.
    Am J Hypertens. 2020 Jun 12. pii: 5856696. doi: 10.1093.
    PubMed         Abstract available


    Angiology

  4. SPENCE JD
    Impaired Renal Function and Cerebrovascular Disease.
    Angiology. 2020;71:489-490.
    PubMed        


    Ann Intern Med

  5. FILION KB, Yu OH
    Sodium-Glucose Cotransporter-2 Inhibitors and Severe Urinary Tract Infections: Reassuring Real-World Evidence.
    Ann Intern Med. 2019 Jul 30. pii: 2739787. doi: 10.7326/M19-1950.
    PubMed        


    Biochem Biophys Res Commun

  6. WANG B, Wu Y, Ge Z, Zhang X, et al
    NLRC5 deficiency ameliorates cardiac fibrosis in diabetic cardiomyopathy by regulating EndMT through Smad2/3 signaling pathway.
    Biochem Biophys Res Commun. 2020 Jun 3. pii: S0006-291X(20)31086.
    PubMed         Abstract available

  7. BALAJI SN, Sahasrabuddhe AA, Trivedi V
    Insulin signalling in RBC is responsible for growth stimulation of malaria parasite in diabetes patients.
    Biochem Biophys Res Commun. 2020 Jun 3. pii: S0006-291X(20)31090.
    PubMed         Abstract available


    BMC Ophthalmol

  8. CANAN H, Sahinoglu-Keskek N, Altan-Yaycioglu R
    The relationship of central corneal thickness with the status of diabetic retinopathy.
    BMC Ophthalmol. 2020;20:220.
    PubMed         Abstract available


    Br J Ophthalmol

  9. CHAMARD C, Daien V, Erginay A, Gautier JF, et al
    Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study.
    Br J Ophthalmol. 2020 Jun 10. pii: bjophthalmol-2020-316030.
    PubMed         Abstract available


    Circ Heart Fail


  10. Longitudinal Changes in Cardiac Structure and Function From Adolescence to Young Adulthood in Participants With Type 2 Diabetes Mellitus: The TODAY Follow-Up Study.
    Circ Heart Fail. 2020 Jun 5:CIRCHEARTFAILURE119006685.
    PubMed         Abstract available


    Circulation

  11. ARNOTT C, Neal B
    Do GLP-1 Receptor Agonists Care if You Have Heart Failure?
    Circulation. 2019;140:1623-1625.
    PubMed        

  12. PETRIE MC
    Sodium Glucose Cotransporter 2 Inhibitors: Searching for Mechanisms in the Wake of Large, Positive Cardiovascular Outcomes Trials.
    Circulation. 2019;140:1703-1705.
    PubMed        

  13. POTPARA TS, Lip GYH
    Combining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease: A Focus on Diabetes Mellitus as a High-Risk Patient Group.
    Circulation. 2020;141:1855-1858.
    PubMed        


    Diabet Med

  14. VAN DEN BOOM L, Kaiser M, Kostev K
    Prevalence of insulin as a first-line therapy and associated factors in people with type 2 diabetes in German primary care practices.
    Diabet Med. 2020 Jun 7. doi: 10.1111/dme.14338.
    PubMed         Abstract available

  15. HEGGIE R, Chappell F, Crawford F, Martin A, et al
    Complication rate among people with diabetes at low risk of foot ulceration in Fife, UK: an analysis of routinely collected data.
    Diabet Med. 2020 Jun 8. doi: 10.1111/dme.14339.
    PubMed         Abstract available

  16. LUK AOY, Kong APS, Basu A
    Young-onset diabetes, nutritional therapy and novel insulin delivery systems: a report from the 21(st) Hong Kong Diabetes and Cardiovascular Risk Factors - East Meets West Symposium.
    Diabet Med. 2020 Jun 8. doi: 10.1111/dme.14335.
    PubMed         Abstract available

  17. CASEY B, Byrne M, Casey D, Gillespie P, et al
    Improving outcomes among young adults with type 1 diabetes: the D1 Now randomized pilot study protocol.
    Diabet Med. 2020 Jun 8. doi: 10.1111/dme.14337.
    PubMed         Abstract available

  18. NG SM, Lay JT, Regan F, Soni A, et al
    Variations in diabetes transition care for children and young people: a national survey.
    Diabet Med. 2020 Jun 8. doi: 10.1111/dme.14336.
    PubMed         Abstract available

  19. DALSGAARD EM, Sandbaek A, Griffin SJ, Rutten GEHM, et al
    Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trial.
    Diabet Med. 2020 Jun 12. doi: 10.1111/dme.14342.
    PubMed         Abstract available

  20. CHATZI G, Mason T, Chandola T, Whittaker W, et al
    Sociodemographic disparities in non-diabetic hyperglycaemia and the transition to type 2 diabetes: evidence from the English Longitudinal Study of Ageing.
    Diabet Med. 2020 Jun 12. doi: 10.1111/dme.14343.
    PubMed         Abstract available

  21. WHITWORTH SR, Bruce DG, Starkstein SE, Davis TME, et al
    Risk factors and outcomes of anxiety symptom trajectories in type 2 diabetes: the Fremantle Diabetes Study Phase II.
    Diabet Med. 2020 Jun 12. doi: 10.1111/dme.14344.
    PubMed         Abstract available

  22. LIPSCOMB D, Smith AS, Adamson S, Rezazadeh EM, et al
    Diabetic foot ulceration in COVID-19 lockdown: cause for concern or unexpected benefit?
    Diabet Med. 2020 Jun 12. doi: 10.1111/dme.14340.
    PubMed         Abstract available


    Diabetes

  23. FLORIJN BW, Duijs JMGJ, Levels JH, Dallinga-Thie GM, et al
    Erratum. Diabetic Nephropathy Alters the Distribution of Circulating Angiogenic MicroRNAs Among Extracellular Vesicles, HDL, and Ago-2. Diabetes 2019;68:2287-2300.
    Diabetes. 2020 Jun 10. pii: db20-er08b. doi: 10.2337.
    PubMed        


    Diabetes Care


  24. Addendum. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2020.
    Diabetes Care. 2020 Jun 5. pii: dc20-ad08b. doi: 10.2337.
    PubMed        


  25. Addendum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020.
    Diabetes Care. 2020 Jun 5. pii: dc20-ad08a. doi: 10.2337.
    PubMed        


  26. Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2020.
    Diabetes Care. 2020 Jun 5. pii: dc20-ad08. doi: 10.2337.
    PubMed        


  27. Addendum. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020.
    Diabetes Care. 2020 Jun 5. pii: dc20-ad08c. doi: 10.2337.
    PubMed        

  28. LU J, Li M, Xu Y, Bi Y, et al
    Early Life Famine Exposure, Ideal Cardiovascular Health Metrics, and Risk of Incident Diabetes: Findings From the 4C Study.
    Diabetes Care. 2020 Jun 4. pii: dc19-2325. doi: 10.2337/dc19-2325.
    PubMed         Abstract available

  29. EBEKOZIEN OA, Noor N, Gallagher MP, Alonso GT, et al
    Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.
    Diabetes Care. 2020 Jun 5. pii: dc20-1088. doi: 10.2337/dc20-1088.
    PubMed        

  30. MADDALONI E, Coraggio L, Pieralice S, Carlone A, et al
    Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy.
    Diabetes Care. 2020 Jun 5. pii: dc20-0954. doi: 10.2337/dc20-0954.
    PubMed        

  31. POWERS MA, Bardsley JK, Cypress M, Funnell MM, et al
    Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care and Education Specialists, the Academy of Nutrition and Dietetics, the American Ac
    Diabetes Care. 2020 Jun 8. pii: dci20-0023. doi: 10.2337/dci20-0023.
    PubMed        

  32. LU J, Home PD, Zhou J
    Comparison of Multiple Cut Points for Time in Range in Relation to Risk of Abnormal Carotid Intima-Media Thickness and Diabetic Retinopathy.
    Diabetes Care. 2020 Jun 11. pii: dc20-0561. doi: 10.2337/dc20-0561.
    PubMed        

  33. PANTALONE KM, Misra-Hebert AD, Hobbs TM, Kong SX, et al
    The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model.
    Diabetes Care. 2020 Jun 11. pii: dc19-0968. doi: 10.2337/dc19-0968.
    PubMed         Abstract available

  34. RENSMA SP, van Sloten TT, Ding J, Sigurdsson S, et al
    Type 2 Diabetes, Change in Depressive Symptoms Over Time, and Cerebral Small Vessel Disease-Longitudinal Data of the AGES-Reykjavik Study.
    Diabetes Care. 2020 Jun 11. pii: dc19-2437. doi: 10.2337/dc19-2437.
    PubMed         Abstract available

  35. ERIKSSON MI, Gordin D, Shams S, Forsblom C, et al
    Nocturnal Blood Pressure Is Associated With Cerebral Small-Vessel Disease in Type 1 Diabetes.
    Diabetes Care. 2020 Jun 11. pii: dc20-0473. doi: 10.2337/dc20-0473.
    PubMed        

  36. MIAO JONASSON J, Hendryx M, Shadyab AH, Kelley E, et al
    Social Support, Social Network Size, Social Strain, Stressful Life Events, and Coronary Heart Disease in Women With Type 2 Diabetes: A Cohort Study Based on the Women's Health Initiative.
    Diabetes Care. 2020 Jun 4. pii: dc19-2065. doi: 10.2337/dc19-2065.
    PubMed         Abstract available


    Diabetes Educ

  37. POWERS MA, Bardsley JK, Cypress M, Funnell MM, et al
    Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Acad
    Diabetes Educ. 2020 Jun 8:145721720930959. doi: 10.1177/0145721720930959.
    PubMed        


    Diabetes Obes Metab

  38. DANNE T, Matsuhisa M, Sussebach C, Goyeau H, et al
    Lower Risk for Severe Hypoglycaemia with Insulin Glargine 300 U/mL vs Glargine 100 U/mL in Participants with Type 1 Diabetes: a Meta-Analysis of 6-Month Phase 3 Clinical Trials.
    Diabetes Obes Metab. 2020 Jun 9. doi: 10.1111/dom.14109.
    PubMed         Abstract available


    Diabetologia

  39. SAVIKJ M, Zierath JR
    Train like an athlete: applying exercise interventions to manage type 2 diabetes.
    Diabetologia. 2020 Jun 11. pii: 10.1007/s00125-020-05166.
    PubMed         Abstract available

  40. RODRIGUES KB, Dufort MJ, Llibre A, Speake C, et al
    Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes.
    Diabetologia. 2020 Jun 5. pii: 10.1007/s00125-020-05179.
    PubMed         Abstract available

  41. DEL PRATO S
    How conclusive is the CONCLUDE trial?
    Diabetologia. 2020;63:692-697.
    PubMed         Abstract available


    Eur J Endocrinol

  42. WANG S, Zhang Y, Lei S, Zhu H, et al
    Performance of deep neural network-based artificial intelligence method in diabetic retinopathy screening: a systematic review and meta-analysis of diagnostic test accuracy.
    Eur J Endocrinol. 2020;183:41-49.
    PubMed         Abstract available

  43. WAKE DJ, Gibb FW, Kar P, Kennon B, et al
    Endocrinology in the time of COVID-19: Remodelling Diabetes Services and Promoting Innovation.
    Eur J Endocrinol. 2020 Jun 5. pii: EJE-20-0377.R1. doi: 10.1530/EJE-20-0377.
    PubMed         Abstract available

  44. DEVUYST F, Kazakou P, Baleriaux D, Alexopoulou O, et al
    Central diabetes insipidus and pituitary stalk thickening in adults: distinction of neoplastic from non-neoplastic lesions.
    Eur J Endocrinol. 2020;181:95-105.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  45. BAUER W, Veijola R, Lempainen J, Kiviniemi M, et al
    Age at Seroconversion, HLA Genotype and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    J Clin Endocrinol Metab. 2019 May 23. pii: 5497099. doi: 10.1210/jc.2019-00421.
    PubMed         Abstract available

  46. TOSUR M, Cleves MA, Sosenko JM, Libman I, et al
    The Effect of Ethnicity in the Rate of Beta Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis.
    J Clin Endocrinol Metab. 2020 Jun 5. pii: 5852376. doi: 10.1210.
    PubMed         Abstract available

  47. BERGMAN M, Abdul-Ghani M, Neves JS, Monteiro MP, et al
    Pitfalls of HbA1c in the Diagnosis of Diabetes.
    J Clin Endocrinol Metab. 2020 Jun 11. pii: 5856154. doi: 10.1210.
    PubMed         Abstract available


    J Diabetes Complications

  48. LANE KL, Abusamaan MS, Voss BF, Thurber EG, et al
    Glycemic control and diabetic foot ulcer outcomes: A systematic review and meta-analysis of observational studies.
    J Diabetes Complications. 2020 May 22:107638.
    PubMed         Abstract available

  49. AN J, Nichols GA, Qian L, Harrison TN, et al
    Time in suboptimal glycemic control over 10years for patients newly diagnosed with type 2 diabetes.
    J Diabetes Complications. 2020 Apr 27:107607.
    PubMed         Abstract available

  50. MUZUROVIC E, Dragnic S, Medenica S, Smolovic B, et al
    Weight-centric pharmacological management of type 2 diabetes mellitus - An essential component of cardiovascular disease prevention.
    J Diabetes Complications. 2020 May 11:107619.
    PubMed         Abstract available

  51. PAUL S, Ali A, Katare R
    Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
    J Diabetes Complications. 2020 May 4:107613. doi: 10.1016/j.jdiacomp.2020.107613
    PubMed         Abstract available

  52. STONE SI, Abreu D, McGill JB, Urano F, et al
    Monogenic and syndromic diabetes due to endoplasmic reticulum stress.
    J Diabetes Complications. 2020 May 8:107618. doi: 10.1016/j.jdiacomp.2020.107618
    PubMed         Abstract available

  53. LEE S, Mey L, Szymanska AF, Takhar HS, et al
    SFDI biomarkers provide a quantitative ulcer risk metric and can be used to predict diabetic foot ulcer onset.
    J Diabetes Complications. 2020 May 19:107624.
    PubMed         Abstract available

  54. SZWARCBARD N, Villani M, Earnest A, Flack J, et al
    The association of smoking status with glycemic control, metabolic profile and diabetic complications- Results of the Australian National Diabetes Audit (ANDA).
    J Diabetes Complications. 2020 May 20:107626.
    PubMed         Abstract available


    J Hypertens

  55. VAN BOMMEL EJM, Smits MM, Ruiter D, Muskiet MHA, et al
    Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes.
    J Hypertens. 2020 Jun 6. doi: 10.1097/HJH.0000000000002480.
    PubMed         Abstract available


    Kidney Int

  56. JENSSEN TG
    Prediabetes after kidney transplantation-a reason to worry?
    Kidney Int. 2019;96:1280-1282.
    PubMed         Abstract available


    Med J Aust

  57. SUBASINGHE AK, Nankervis AJ, Boyle JA, Mazza D, et al
    Optimising the implementation of guidelines for the post partum testing and management of gestational diabetes in South Asian women in Australia.
    Med J Aust. 2020 Jun 11. doi: 10.5694/mja2.50660.
    PubMed        


    N Engl J Med

  58. RUBINO F, Amiel SA, Zimmet P, Alberti G, et al
    New-Onset Diabetes in Covid-19.
    N Engl J Med. 2020 Jun 12. doi: 10.1056/NEJMc2018688.
    PubMed        


    Nature

  59. SPRACKLEN CN, Horikoshi M, Kim YJ, Lin K, et al
    Identification of type 2 diabetes loci in 433,540 East Asian individuals.
    Nature. 2020;582:240-245.
    PubMed         Abstract available


    Ophthalmol Retina

  60. ANTOSZYK AN, Tarnowski KW, Basu K, Ehrlich JS, et al
    Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.
    Ophthalmol Retina. 2020 Jun 5. pii: S2468-6530(20)30218.
    PubMed         Abstract available


    Pediatr Diabetes

  61. BUTLER AM, Weller BE, Rodgers CRR, Teasdale AE, et al
    Type 1 Diabetes Self-Management Behaviors among Emerging Adults: Racial/Ethnic Differences.
    Pediatr Diabetes. 2020 Jun 7. doi: 10.1111/pedi.13061.
    PubMed         Abstract available

  62. SHAH N, Khadilkar A, Gondhalekar K, Khadilkar V, et al
    Prevalence of Dyslipidemia in Indian Children with Poorly Controlled Type 1 Diabetes Mellitus.
    Pediatr Diabetes. 2020 Jun 7. doi: 10.1111/pedi.13063.
    PubMed         Abstract available

  63. GALLER A, Hilgard D, Bollow E, Hermann T, et al
    Psychological care in children and adolescents with type 1 diabetes in a real-world setting and associations with metabolic control.
    Pediatr Diabetes. 2020 Jun 7. doi: 10.1111/pedi.13065.
    PubMed         Abstract available

  64. TRYGGESTAD JB, Shah RD, Braffett BH, Bacha F, et al
    Circulating Adhesion Molecules and Associations with HbA1c, Hypertension, Nephropathy, and Retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth (TODAY) Study.
    Pediatr Diabetes. 2020 Jun 5. doi: 10.1111/pedi.13062.
    PubMed         Abstract available


    PLoS Med

  65. IMAMURA F, Fretts AM, Marklund M, Ardisson Korat AV, et al
    Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
    PLoS Med. 2020;17:e1003102.
    PubMed         Abstract available


    PLoS One

  66. NAKANO K, Yanobu-Takanashi R, Shimizu Y, Takahashi Y, et al
    Genetic locus responsible for diabetic phenotype in the insulin hyposecretion (ihs) mouse.
    PLoS One. 2020;15:e0234132.
    PubMed         Abstract available

  67. DABHI PA, Thangakunam B, Gupta R, James P, et al
    Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital.
    PLoS One. 2020;15:e0233385.
    PubMed         Abstract available

  68. CONSOLAZIO D, Koster A, Sarti S, Schram MT, et al
    Neighbourhood property value and type 2 diabetes mellitus in the Maastricht study: A multilevel study.
    PLoS One. 2020;15:e0234324.
    PubMed         Abstract available

  69. LEE CH, Choi SW, Jun SW, Hwang J, et al
    Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry.
    PLoS One. 2020;15:e0234362.
    PubMed         Abstract available

  70. SAE-LEE C, Biasi J, Robinson N, Barrow TM, et al
    DNA methylation patterns of LINE-1 and Alu for pre-symptomatic dementia in type 2 diabetes.
    PLoS One. 2020;15:e0234578.
    PubMed         Abstract available

  71. MEINDL C, Hochadel M, Frankenstein L, Bruder O, et al
    The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registry.
    PLoS One. 2020;15:e0234260.
    PubMed         Abstract available

  72. MARQUES AM, Linhares BS, Dias Novaes R, Freitas MB, et al
    Effects of the amount and type of carbohydrates used in type 2 diabetes diets in animal models: A systematic review.
    PLoS One. 2020;15:e0233364.
    PubMed         Abstract available

  73. BEDNAREK M
    Invisible or high-risk: Computer-assisted discourse analysis of references to Aboriginal and Torres Strait Islander people(s) and issues in a newspaper corpus about diabetes.
    PLoS One. 2020;15:e0234486.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: